Latest Charles River Laboratories News & Updates

See the latest news and media coverage for Charles River. We track all announcements, press releases, and industry mentions in real time, all in one place.

Charles River Laboratories (Charles River)

Life sciences research, drug development, and manufacturing services provider

criver.com

Headquarters: Wilmington, United States
Founded year: 1947
Company type: Public company
Number of employees: 14,000+
Industry: Biotechnology & Medical Research

Last updated September 24

Latest news about Charles River Laboratories (Charles River)

In short: Charles River raised its 2026 guidance as Q2 growth turned positive on improving demand

Company announcements

September 24 Charles River

Charles River outlines refreshed strategic vision at 2026 Investor Day

The company highlights the Pathway to Purpose strategy and sets long-term financial targets through 2030 while reaffirming 2026 guidance.

August 5 Charles River

Charles River reports Q2 results and raises 2026 guidance

Revenue reached $1.00 billion with non-GAAP EPS of $3.02; organic growth turned positive, and improved demand drove the guidance increase.

May 7 Charles River

Charles River announces Q1 2026 results

Revenue reaches $995.8 million, up 1.2%. Non-GAAP EPS is $2.06. Reaffirms 2026 guidance. Completes CDMO divestiture. Repurchases $200 million stock.

February 25 Charles River

Charles River announces planned divestitures

Signs agreements to sell CDMO and Cell Solutions to GI Partners, and certain European Discovery assets to IQVIA. Updates 2026 financial guidance assuming Q2 closure.

Media coverage

September 17 RTTNews

Charles River Laboratories Stock Rises 6% After Unveiling 2030 Growth Targets

Charles River Laboratories International, Inc. (CRL) is up 5.70 percent, gaining $15.80 to $293.13 on Thursday. The move comes after the company unveiled its "Pathway...

August 5 MSN

Charles River says biotech demand is back — bookings hit four-year high

Charles River Laboratories International Inc. CRL stock traded higher Wednesday after the contract research organization raised its full-year 2026 financial guidance following second-quarter results that...

August 5 RTTNews

Charles River Posts Loss In Q2; Increases 2026 Guidance For Revenue, Non-GAAP EPS

Charles River Laboratories International (CRL) reported a second quarter net loss attributable to common shareholders of $1.48 million compared to net income of $52.

August 5 Investing.com

Charles River Labs stock climbs 8% on Q2 beat, raised guidance By Investing.com

WILMINGTON, Mass. -On Wednesday, Charles River Laboratories International (NYSE:CRL) delivered second-quarter results that exceeded analyst expectations and raised full-year guidance, driven by improving demand trends...

Never miss news about Charles River

Track Charles River and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Charles River competitors & trending companies

Browse news for competitors to Charles River and other trending companies.